The impact of diagnosis of hepatitis C virus on quality of life
Lisa Forman, Steven Kawut, Ilene Rosen, Grace Pien, Hillary Bogner – 30 December 2003
Liver transplantation is effective, but is it cost‐effective?
Kiran Bambha, W. Ray Kim – 30 December 2003
Reply
Alan S. Perelson, Ruy M. Ribeiro, Jennifer E. Layden‐Almer, Thomas J. Layden – 30 December 2003
Transcription factors in liver development, differentiation, and regeneration
Robert H. Costa, Vladimir V. Kalinichenko, Ai‐Xuan L. Holterman, Xinhe Wang – 30 December 2003
Viral kinetics and hepatitis C
Gerond Lake‐Bakaar, Simon D. W. Frost – 30 December 2003
Reply to Role of Echocardiography in detecting portopulmonary hypertension in liver transplant candidates
M. George DeBusk, Yoogoo Kang, Cataldo Doria, Victor J. Navarro, Ignazio R. Marino, Howard R. Doyle – 30 December 2003
Hepatitis C and mycophenolate mofetil—a clarification
Carlos G. Fasola, Goran B. Klintmalm – 30 December 2003
Aberrant right hepatic artery: A mockery
George N. Tzimas, Jeffrey S.T. Barkun, Peter Metrakos, Jean I. Tchervenkov – 30 December 2003
The real danger of lamivudine‐resistant hepatitis B virus infection in the immunocompromised host
Hugo E. Vargas – 30 December 2003 – In many transplant centres lamivudine is an important component of prophylaxis against, and treatment of, hepatitis B virus (HBV) graft infection. Drug resistant HBV species with specific polymerase mutations may emerge during lamivudine treatment. Aims: To examine the clinical consequences of graft infection by lamivudine resistant virus. Methods: The clinical course of four liver transplant patients who developed graft infection with lamivudine resistant virus was reviewed.
Improvement of hepatorenal syndrome with extracorporeal albumin dialysis mars: Results of a prospective, randomized, controlled clinical trial
Steffen R. Mitzner, Jan Stange, Sebastian Klammt, Teut Risler, Christiane M. Erley, Brigitte D. Bader, Elke D. Berger, Werner Lauchart, Piotr Peszynski, Jens Freytag, Heiko Hickstein, Jan Loock, Johannes‐Mathias Löhr, Stefan Liebe, Jörg Emmrich, Gero Korten, Reinhard Schmidt – 30 December 2003 – In hepatorenal syndrome (HRS), renal insufficiency is often progressive, and the prognosis is extremely poor under standard medical therapy.